Nuveen LLC Takes $449,000 Position in Utah Medical Products, Inc. $UTMD

Key Points

• Nuveen LLC acquired 8,018 shares of Utah Medical Products, Inc. for approximately $449,000, raising its stake to about 0.24% of the company.
• Utah Medical Products recently declared a quarterly dividend of $0.305 per share, resulting in an annualized yield of 1.9% based on a payout ratio of 32.62%.
• The company reported earnings of $0.94 per share with revenues of $9.95 million, showcasing a net margin of 32.34% in its latest financial results.

Nuveen LLC bought a new position in Utah Medical Products, Inc. (NASDAQ:UTMD - Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 8,018 shares of the medical instruments supplier's stock, valued at approximately $449,000. Nuveen LLC owned 0.24% of Utah Medical Products at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Invesco Ltd. acquired a new position in Utah Medical Products in the 1st quarter worth $207,000. Everett Harris & Co. CA boosted its stake in shares of Utah Medical Products by 327.7% during the 1st quarter. Everett Harris & Co. CA now owns 17,116 shares of the medical instruments supplier's stock worth $959,000 after buying an additional 13,114 shares during the last quarter. Bard Associates Inc. raised its holdings in Utah Medical Products by 5.0% during the first quarter. Bard Associates Inc. now owns 21,032 shares of the medical instruments supplier's stock worth $1,185,000 after acquiring an additional 1,002 shares in the last quarter. Deutsche Bank AG raised its holdings in Utah Medical Products by 321.9% during the first quarter. Deutsche Bank AG now owns 2,983 shares of the medical instruments supplier's stock worth $167,000 after acquiring an additional 2,276 shares in the last quarter. Finally, Minerva Advisors LLC raised its holdings in Utah Medical Products by 10.9% during the first quarter. Minerva Advisors LLC now owns 86,902 shares of the medical instruments supplier's stock worth $4,870,000 after acquiring an additional 8,513 shares in the last quarter. 69.60% of the stock is owned by institutional investors and hedge funds.

Utah Medical Products Stock Performance

UTMD traded down $0.05 on Monday, hitting $63.35. 6,630 shares of the company were exchanged, compared to its average volume of 17,671. Utah Medical Products, Inc. has a 12 month low of $51.26 and a 12 month high of $68.99. The company has a market cap of $203.35 million, a PE ratio of 16.94 and a beta of 0.32. The stock's fifty day moving average is $57.98 and its 200-day moving average is $56.30.

Utah Medical Products (NASDAQ:UTMD - Get Free Report) last released its earnings results on Thursday, July 24th. The medical instruments supplier reported $0.94 earnings per share (EPS) for the quarter. Utah Medical Products had a return on equity of 10.55% and a net margin of 32.34%.The business had revenue of $9.95 million for the quarter.

Utah Medical Products Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, October 2nd. Investors of record on Wednesday, September 17th will be issued a dividend of $0.305 per share. This represents a $1.22 annualized dividend and a yield of 1.9%. The ex-dividend date is Wednesday, September 17th. Utah Medical Products's dividend payout ratio is presently 32.62%.

Utah Medical Products Company Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.